Follow
Amy Foulkes
Amy Foulkes
Verified email at manchester.ac.uk
Title
Cited by
Cited by
Year
Brodalumab in psoriasis: evidence to date and clinical potential
AC Foulkes, RB Warren
Drugs in Context 8, 2019
762019
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature
A Weidmann, AC Foulkes, N Kirkham, NJ Reynolds
Dermatology and therapy 4, 145-156, 2014
592014
Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review
A Al‐Janabi, AC Foulkes, K Mason, CH Smith, CEM Griffiths, RB Warren
Journal of the European Academy of Dermatology and Venereology 34 (7), 1440-1448, 2020
502020
A framework for multi-omic prediction of treatment response to biologic therapy for psoriasis
AC Foulkes, DS Watson, DF Carr, JG Kenny, T Slidel, R Parslew, ...
Journal of Investigative Dermatology 139 (1), 100-107, 2019
362019
Research techniques made simple: bioinformatics for genome-scale biology
AC Foulkes, DS Watson, CEM Griffiths, RB Warren, W Huber, MR Barnes
Journal of Investigative Dermatology 137 (9), e163-e168, 2017
232017
Pharmacogenomics and the resulting impact on psoriasis therapies
AC Foulkes, RB Warren
Dermatologic clinics 33 (1), 149-160, 2015
212015
What’s new in psoriasis? An analysis of guidelines and systematic reviews published in 2009–2010
AC Foulkes, DJC Grindlay, CEM Griffiths, RB Warren
Clinical and experimental dermatology 36 (6), 585-589, 2011
212011
High degree of patient satisfaction and exceptional feedback in a specialist combined dermatology and rheumatology clinic
AC Foulkes, H Chinoy, RB Warren
British Association of Dermatologists' Annual Meeting, 2012
142012
Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis
AC Foulkes, L Wheeler, D Gosal, CEM Griffiths, RB Warren
British Journal of Dermatology 170 (1), 206-209, 2014
132014
International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis
AM Van Huizen, SP Menting, R Gyulai, L Iversen, GE Van Der Kraaij, ...
JAMA dermatology 158 (5), 561-572, 2022
122022
Paradoxical eczema in patients with psoriasis receiving biologics: a case series
A Al‐Janabi, AC Foulkes, CEM Griffiths, RB Warren
Clinical and Experimental Dermatology 47 (6), 1174-1178, 2022
102022
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
L Tucker, A Allen, D Chandler, C Ciurtin, A Dick, A Foulkes, N Gullick, ...
Rheumatology 61 (9), e255-e266, 2022
92022
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope
W Tillett, A Allen, L Tucker, D Chandler, C Ciurtin, C Davis, A Dick, ...
Rheumatology 60 (4), 1588-1592, 2021
92021
Atopic polygenic risk score is associated with paradoxical eczema developing in patients with psoriasis treated with biologics
A Al-Janabi, S Eyre, AC Foulkes, AR Khan, N Dand, E Burova, B DeSilva, ...
Journal of Investigative Dermatology 143 (8), 1470-1478. e1, 2023
82023
What's new in psoriasis treatment? An analysis of systematic reviews published in 2015
AC Foulkes, F Ferguson, DJC Grindlay, HC Williams, CEM Griffiths, ...
Clinical and Experimental Dermatology 43 (7), 759-765, 2018
52018
Palmoplantar contractures in childhood: a rare complication of vascular Ehlers–Danlos syndrome
AC Foulkes, R Pollitt, G Sobey, FM Pope, AEM Taylor
Clinical and Experimental Dermatology 38 (5), 517-519, 2013
52013
What’s new in psoriasis
AC Foulkes, DJ Grindlay, CE Griffiths, RB Warren
An analysis of guidelines and systematic reviews published in 2010, 585-94, 2009
42009
Maintaining clinical freedom whilst achieving value in biologics prescribing: an integrated cross-specialty consensus of UK dermatologists, rheumatologists and gastroenterologists
T Raine, MA Gkini, PM Irving, A Kaul, E Korendowych, P Laws, ...
BioDrugs 35, 187-199, 2021
32021
Patients' narratives
AC Foulkes, RB Warren
Dermatological Diseases and Cumulative Life Course Impairment 44, 145-157, 2013
32013
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study
A Al-Janabi, A Ra, Z Littlewood, AC Foulkes, HJA Hunter, H Chinoy, ...
British Journal of Dermatology 188 (4), 542-551, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20